natgillin/translations-raw huggingface dataset:
Alkanes, C10-13, chloro (Short Chain Chlorinated Paraffins – SCCPs) are persistent, bioaccumulative and toxic, and very persistent and very bioaccumulative in accordance with the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 pursuant to Article 57(d) and (e) respectively and set out in Annex XIII to that Regulation.
V skladu z merili za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 iz člena 57(d) oziroma (e), določenimi v Prilogi XIII k navedeni uredbi, so alkani, C10-13, kloro (klorirani parafini s kratkimi verigami) obstojni, se kopičijo v organizmih in so strupeni ter so zelo obstojni in se zelo kopičijo v organizmih.
They have been identified and included in the candidate list in accordance with Article 59 of that Regulation.
Te snovi so bile identificirane in vključene v seznam snovi v skladu s členom 59 navedene uredbe.
Hexabromocyclododecane (HBCDD) and the diastereoisomers alpha-, beta- and gamma-hexabromocyclododecane are persistent, bioaccumulative and toxic in accordance with the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 pursuant to Article 57(d) and set out in Annex XIII to that Regulation.
V skladu z merili za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 iz člena 57(d), določenimi v Prilogi XIII k navedeni uredbi, so heksabromociklododekan (HBCDD) ter diastereoizomeri alfa-, beta- in gama-heksabromociklododekan obstojni, se kopičijo v organizmih in so strupeni.
Bis(2-ethylhexyl) phthalate (DEHP) meets the criteria for classification as toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 pursuant to Article 57(c) of that Regulation.
Bis(2-etilheksil) ftalat (DEHP) izpolnjuje merila za razvrstitev kot strupen za razmnoževanje (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 v skladu s členom 57(c) navedene uredbe.
Benzyl butyl phthalate (BBP) meets the criteria for classification as toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 pursuant to Article 57(c) of that Regulation.
Benzil butil ftalat (BBP) izpolnjuje merila za razvrstitev kot strupen za razmnoževanje (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 v skladu s členom 57(c) navedene uredbe.
Dibutyl phthalate (DBP) meets the criteria for classification as toxic for reproduction (category 1B) in accordance with Regulation (EC) No 1272/2008 and therefore meets the criteria for inclusion in Annex XIV to Regulation (EC) No 1907/2006 pursuant to Article 57(c) of that Regulation.
Dibutil ftalat (DBP) izpolnjuje merila za razvrstitev kot strupen za razmnoževanje (skupina 1B) v skladu z Uredbo (ES) št. 1272/2008, zato izpolnjuje tudi merila za vključitev v Prilogo XIV k Uredbi (ES) št. 1907/2006 v skladu s členom 57(c) navedene uredbe.
The abovementioned substances have been prioritised for inclusion in Annex XIV to Regulation (EC) No 1907/2006 by the European Chemicals Agency in its recommendation of 1 June 2009 [4] in accordance with Article 58 of that Regulation.
(10) Evropska agencija za kemikalije je v priporočilu z dne 1. junija 2009 [4] v skladu s členom 58 Uredbe (ES) št. 1907/2006 navedenim snovem dala prednost za vključitev v Prilogo XIV k navedeni uredbi.
For each substance listed in Annex XIV to Regulation (EC) No 1907/2006, where the applicant wishes to continue to use the substance or place the substance on the market, it is appropriate to set a date by which applications must be received by the European Chemicals Agency, in accordance with Article 58(1)(c)(ii) of that Regulation.
Za vsako snov iz Priloge XIV k Uredbi (ES) št. 1907/2006, kadar vložnik želi snov še naprej uporabljati ali jo dati v promet, je v skladu s členom 58(1)(c)(ii) navedene uredbe primerno določiti datum, do katerega mora Evropska agencija za kemikalije prejeti zahtevke.
For each substance listed in Annex XIV to Regulation (EC) No 1907/2006 it is appropriate to set a date from which the use and placing on the market is prohibited, in accordance with Article 58(1)(c)(i) of that Regulation.
Za vsako snov iz Priloge XIV k Uredbi (ES) št. 1907/2006 je v skladu s členom 58(1)(c)(i) navedene uredbe primerno določiti datum, od katerega sta uporaba in dajanje v promet prepovedana.
The European Chemicals Agency recommendation of 1 June 2009 has identified different latest application dates for the substances listed in the Annex to this Regulation.
Priporočilo Evropske agencije za kemikalije z dne 1. junija 2009 določa različne zadnje datume uporabe za snovi iz Priloge k tej uredbi.
These dates should be set on the basis of the estimated time that would be required to prepare an application for the authorisation, taking into account the information available on the different substances and specifically the information received during the public consultation carried out in accordance with Article 58(4) of Regulation (EC) No 1907/2006.
Te datume je treba določiti glede na predviden čas, potreben za pripravo zahtevka za avtorizacijo, ob upoštevanju razpoložljivih informacij o različnih snoveh in zlasti informacij, prejetih na javnih posvetovanjih, opravljenih v skladu s členom 58(4) Uredbe (ES) št. 1907/2006.
Factors such as the number of actors in the supply chain, their homogeneity or heterogeneity, the existence of ongoing substitution efforts and information on potential alternatives and the expected complexity of the preparation of the analysis of alternatives should be taken into account.
Upoštevati je treba dejavnike, kot so število akterjev v preskrbovalni verigi, njihova homogenost ali heterogenost, tekoča prizadevanja za nadomestitev in informacije o alternativnih možnostih ter pričakovana kompleksnost priprave analize alternativnih možnosti.
In accordance with Article 58(1)(c)(ii) of Regulation (EC) No 1907/2006, the latest application date is to be set at least 18 months before the sunset date.
V skladu s členom 58(1)(c)(ii) Uredbe (ES) št. 1907/2006 mora biti datum zadnje uporabe vsaj 18 mesecev pred datumom poteka.
Article 58(1)(e) in conjunction with Article 58(2) of Regulation (EC) No 1907/2006 provides for the possibility of exemptions of uses or categories of uses in cases where there is specific Community legislation imposing minimum requirements relating to the protection of human health or the environment that ensures proper control of the risks.
Člen 58(1)(e) v povezavi s členom 58(2) Uredbe (ES) št. 1907/2006 določa možnost izvzetja uporab ali kategorij uporab, kadar posebna zakonodaja Skupnosti določa minimalne zahteve v zvezi z varovanjem zdravja ljudi ali okolja za zagotovitev primernega nadzora tveganj.
DEHP, BBP, and DBP are used in the immediate packaging of medicinal products.
Bis(2-etilheksil) ftalat, benzil butil ftalat in dibutil ftalat se uporabljajo v stični ovojnini zdravil.
Aspects of safety of the immediate packaging of medicines are covered by Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products [6] and Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use [7].
Vidiki varnosti stične ovojnine zdravil so zajeti v Direktivi Evropskega parlamenta in Sveta 2001/82/ES z dne 6. novembra 2001 o zakoniku Skupnosti o zdravilih za uporabo v veterinarski medicini [6] ter Direktivi Evropskega parlamenta in Sveta 2001/83/ES z dne 6. novembra 2001 o zakoniku Skupnosti o zdravilih za uporabo v humani medicini [7].
That legislation of the Union provides for a framework to properly control risks of such immediate packaging materials by imposing requirements on the quality, stability, and safety of the immediate packaging materials.
Navedena zakonodaja Unije določa okvir za primeren nadzor tveganj pri takšnih materialih za stično ovojnino z uvedbo zahtev glede kakovosti, stabilnosti in varnosti materialov za stično ovojnino.
It is therefore appropriate to exempt the use of DEHP, BBP, and DBP in the immediate packaging of medicinal products from authorisation under Regulation (EC) No 1907/2006.
Zato je primerno izvzeti uporabo bis(2-etilheksil) ftalata, benzil butil ftalata in dibutil ftalata v stični ovojnini zdravil iz avtorizacije v skladu z Uredbo (ES) št. 1907/2006.
In accordance with Article 60(2) of Regulation (EC) No 1907/2006, the Commission should not consider, when granting authorisations, the human health risks associated with the use of substances in medical devices regulated by Council Directive 90/385/EEC of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices [8], Council Directive 93/42/EEC of 14 June 1993 concerning medical devices [9], or Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices [10].
Komisija pri dodelitvi avtorizacij v skladu s členom 60(2) Uredbe (ES) št. 1907/2006 ne sme upoštevati tveganj za zdravje ljudi, ki izhajajo iz uporabe snovi v medicinskem pripomočku in jih urejajo Direktiva Sveta 90/385/EGS z dne 20. junija 1990 o približevanju zakonodaje držav članic o aktivnih medicinskih pripomočkih za vsaditev [8], Direktiva Sveta 93/42/EGS z dne 14. junija 1993 o medicinskih pripomočkih [9] ali Direktiva 98/79/ES Evropskega parlamenta in Sveta z dne 27. oktobra 1998 o in vitro diagnostičnih medicinskih pripomočkih [10].
In addition, Article 62(6) of Regulation (EC) No 1907/2006 provides that applications for authorisation should not include the risks to human health arising from the use of a substance in a medical device regulated under those Directives.
Člen 62(6) Uredbe (ES) št. 1907/2006 poleg tega določa, da zahtevki za avtorizacijo ne smejo vključevati tveganj za zdravje ljudi, ki izhajajo iz uporabe snovi v medicinskem pripomočku in jih urejajo navedene direktive.
It follows that an application for an authorisation should not be required for a substance used in medical devices regulated under Directives 90/385/EEC, 93/42/EEC, or 98/79/EC if such a substance has been identified in Annex XIV to Regulation (EC) No 1907/2006 for human health concerns only.
Iz tega sledi, da se zahtevek za avtorizacijo ne sme zahtevati za snov, ki se uporablja v medicinskih pripomočkih in jo urejajo Direktive 90/385/EGS, Direktiva 93/42/EGS ali Direktiva 98/79/ES, če je taka snov v Prilogi XIV k Uredbi (ES) št. 1907/2006 opredeljena samo zaradi pomislekov za zdravje ljudi.
Therefore, an assessment as to whether the conditions for an exemption pursuant to Article 58(2) of Regulation (EC) No 1907/2006 apply is not necessary.
Zato ni treba oceniti, ali veljajo pogoji za odobritev izvzetja v skladu s členom 58(2) Uredbe (ES) št. 1907/2006.
On the basis of the information currently available it is not appropriate to set exemptions for product and process orientated research and development.
Na podlagi trenutno razpoložljivih informacij ni primerno določiti izvzetij za raziskave in razvoj, usmerjene v proizvod in proces.
On the basis of the information currently available it is not appropriate to set review periods for certain uses.
Na podlagi trenutno razpoložljivih informacij ni primerno določiti rokov za pregled za nekatere uporabe.
The measures provided for in this Regulation are in accordance with the opinion of the Committee established pursuant to Article 133 of Regulation (EC) No 1907/2006,
Ukrepi, predvideni s to uredbo, so v skladu z mnenjem odbora, ustanovljenega v skladu s členom 133 Uredbe (ES) št. 1907/2006 –
Annex XIV to Regulation (EC) No 1907/2006 is amended in accordance with the Annex to this Regulation.
Priloga XIV k Uredbi (ES) št. 1907/2006 se spremeni v skladu s Prilogo k tej uredbi.
In Annex XIV to Regulation (EC) No 1907/2006 the following table is inserted:
V Prilogo XIV k Uredbi (ES) št. 1907/2006 se vstavi naslednja preglednica:
‘Entry Nr
„Vnos št.
Intrinsic property(ies) referred to in Article 57
Intrinzične lastnosti iz člena 57
Exempted (categories of) uses
Izvzete uporabe (kategorije uporab)
Review periods
Roki za pregled
Latest application date [1]
Datum zadnje uporabe [1]
Sunset date [2]
Datum poteka [2]
5-tert-butyl-2,4,6-trinitro-m-xylene
5-terc-butil-2,4,6-trinitro-m-ksilen
(Musk xylene)
(mošusov ksilen)
EC No 201-329-4
št. EC 201-329-4
CAS No 81-15-2
št. CAS 81-15-2
21 January 2013
21. januar 2013
21 July 2014
21. julij 2014
EC No 202-974-4
št. EC 202-974-4
CAS No 101-77-9
št. CAS 101-77-9
Carcinogenic
rakotvoren
(category 1B)
(skupina 1B)
EC No 221-695-9,
št. EC 221-695-9,
CAS No 3194-55-6
št. CAS 3194-55-6
alpha-hexabromocyclododecane
alfa-heksabromociklododekan
CAS No 134237-50-6,
št. CAS 134237-50-6,
beta-hexabromocyclododecane
beta-heksabromociklododekan
CAS No 134237-51-7
št. CAS 134237-51-7
gamma-hexabromocyclododecane
gama-heksabromociklododekan
CAS No 134237-52-8
št. CAS 134237-52-8
21 January 2014
21. januar 2014
21 July 2015
21. julij 2015
Bis(2-ethylhexyl) phthalate
Bis(2-etilheksil)ftalat
EC No 204-211-0
št. EC 204-211-0
Toxic for reproduction
strupen za razmnoževanje
21 July 2013
21. julij 2013
21 January 2015
21. januar 2015
Uses in the immediate packaging of medicinal products covered under Regulation (EC) No 726/2004, Directive 2001/82/EC, and/or Directive 2001/83/EC.
Uporabe v stični ovojnini zdravil v skladu z Uredbo (ES) št. 726/2004, Direktivo 2001/82/ES in/ali Direktivo 2001/83/ES.
EC No 201-622-7
št. EC 201-622-7
EC No 201-557-4
št. EC 201-557-4
Date referred to in Article 58(1)(c)(ii) of Regulation (EC) No 1907/2006.
Datum iz člena 58(1)(c)(ii) Uredbe (ES) št. 1907/2006.
Date referred to in Article 58(1)(c)(i) of Regulation (EC) No 1907/2006.’
Datum iz člena 58(1)(c)(i) Uredbe (ES) št. 1907/2006.“
In December 2009, SCCPs were included as a persistent organic pollutant under the 1998 Protocol on Persistent Organic Pollutants to the 1979 Convention on Long-Range Transboundary Air Pollution.
(11) Decembra 2009 so klorirani parafini s kratkimi verigami bili vključeni kot obstojna organska onesnaževala v Protokol iz leta 1998 o obstojnih organskih onesnaževalih h Konvenciji iz leta 1979 o onesnaževanju zraka na velike razdalje preko meja.
The inclusion of SCCPs in this Protocol has triggered additional obligations for the European Union under Regulation (EC) No 850/2004 of the European Parliament and of the Council of 29 April 2004 on persistent organic pollutants and amending Directive 79/117/EEC [5] that could have an impact on the inclusion at this stage of SCCPs in Annex XIV to Regulation (EC) No 1907/2006.
Zaradi vključitve kloriranih parafinov s kratkimi verigami v ta protokol ima Evropska unija dodatne obveznosti v skladu z Uredbo (ES) št. 850/2004 Evropskega parlamenta in Sveta z dne 29. aprila 2004 o obstojnih organskih onesnaževalih in spremembi Direktive 79/117/EGS [5], kar bi lahko na tej stopnji vplivalo na vključitev kloriranih parafinov s kratkimi verigami v Prilogo XIV k Uredbi (ES) št. 1907/2006.
Corrigendum to Commission Regulation (EU) No 143/2011 of 17 February 2011 amending Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (‘REACH’)
Uredba Komisije (EU) št. 143/2011 z dne 17. februarja 2011 o spremembi Priloge XIV k Uredbi (ES) št. 1907/2006 Evropskega parlamenta in Sveta o registraciji, evalvaciji, avtorizaciji in omejevanju kemikalij („REACH“)
(Official Journal of the European Union L 44 of 18 February 2011)
(Uradni list Evropske unije L 44 z dne 18. februarja 2011)
On page 5, the Annex is replaced by the following text:
Stran 5, Priloga se nadomesti z naslednjim besedilom:
21 February 2013
21. februar 2013
21 August 2014
21. avgust 2014
21 February 2014
21. februar 2014
21 August 2015
21. avgust 2015
21 August 2013
21. avgust 2013
21 February 2015
21. februar 2015
Date referred to in Article 58(1)(c)(i) of Regulation (EC) No 1907/2006.’
Datum iz člena 58(1)(c)(i) Uredbe (ES) št. 1907/2006.“ “
Commission Regulation (EU) No 144/2011
Uredba Komisije (EU) št. 144/2011
Having regard to Council Directive 2002/99/EC of 16 December 2002 laying down the animal health rules governing the production, processing, distribution and introduction of products of animal origin for human consumption [1], and in particular the introductory phrase of Article 8, the first subparagraph of Article 8(1) and Article 9(2)(b) thereof,
ob upoštevanju Direktive Sveta 2002/99/ES z dne 16. decembra 2002 o predpisih v zvezi z zdravstvenim varstvom živali, ki urejajo proizvodnjo, predelavo, distribucijo in uvoz proizvodov živalskega izvora, namenjenih prehrani ljudi [1], in zlasti uvodnega stavka člena 8, prvega pododstavka člena 8(1) in člena 9(2)(b) Direktive,
Having regard to Council Directive 2004/68/EC of 26 April 2004 laying down animal health rules for the importation into and transit through the Community of certain live ungulate animals, amending Directives 90/426/EEC and 92/65/EEC and repealing Directive 72/462/EEC [2], and in particular the first subparagraph of Article 6(1) and Article 7(e) thereof,
ob upoštevanju Direktive Sveta 2004/68/ES z dne 26. aprila 2004 o določitvi predpisov v zvezi z zdravstvenim varstvom živali za uvoz v Skupnost in tranzit skozi Skupnost nekaterih živih parkljarjev, o spremembi direktiv 90/426/ES in 92/65/EGS ter razveljavitvi Direktive 72/462/EGS [2] in zlasti prvega pododstavka člena 6(1) in člena 7(e) Direktive,
Council Directive 64/432/EEC of 26 June 1964 on animal health problems affecting intra-Community trade in bovine animals and swine [3] applies to intra-Union trade in bovine animals.
Direktiva Sveta 64/432/EGS z dne 26. junija 1964 o problemih v zvezi z zdravstvenim varstvom živali, ki vplivajo na trgovino z govedom in prašiči znotraj Skupnosti [3] se uporablja za trgovino z govedom znotraj Unije.
It provides that bovine animals for breeding and production must come from an officially enzootic-bovine-leukosis-free herd and if more than 12 months old, have reacted negatively to an individual test carried out during the 30 days prior to leaving the herd of origin and complying with the provisions of Annex D thereto.
Določa, da mora govedo za vzrejo in proizvodnjo prihajati iz črede, uradno proste enzootske goveje levkoze, in je v primeru živali, starejših od 12 mesecev, reagiralo negativno na individualni test, opravljen v 30 dneh pred premikom iz izvorne črede in v skladu z določbami Priloge D k Direktivi.
Directive 64/432/EEC also sets out diagnostic tests to be used for brucellosis and the certification requirements for intra-Union trade in bovine animals for breeding and production.
Direktiva 64/432/EGS določa tudi diagnostične teste, ki jih je treba uporabiti za brucelozo, in zahteve v zvezi z izdajanjem spričeval za trgovino z govedom za vzrejo ali proizvodnjo v Uniji.
In addition, that Directive, as amended by Commission Decision 2008/984/EC [4], now includes fluorescence polarization assay as a standard diagnostic test.
Poleg tega navedena direktiva, kakor je bila spremenjena z Odločbo Komisije 2008/984/ES [4], zdaj vključuje test s fluorescentnimi označevalci kot standardni diagnostični test.
Directive 2004/68/EC lays down the animal health requirements for the importation into, and transit through, the Union of live ungulates.
Direktiva 2004/68/ES določa zahteve glede zdravstvenega varstva živali za uvoz v Unijo in tranzit skozi Unijo živih kopitarjev.
Those requirements include specific animal health requirements for live ungulates which are to be based on the rules laid down in Union legislation for the diseases to which those animals are susceptible.
Navedene zahteve vključujejo specifične zahteve glede zdravstvenega stanja živih kopitarjev, ki morajo temeljiti na pravilih, določenih v zakonodaji Unije v zvezi z boleznimi, za katere so dovzetne navedene živali.
Directive 2004/68/EC also provides that specific conditions may be laid down for third countries for which equivalence has been formally recognised by the Union based on the official health guarantees provided by the third country concerned.
Direktiva 2004/68/ES navaja tudi, da se lahko določijo specifični pogoji za tretje države, za katere je Unija uradno prepoznala enakovrednost na podlagi uradnih jamstev glede zdravstvenega varstva, ki jih predložijo zadevne tretje države.
Commission Regulation (EU) No 206/2010 of 12 March 2010 laying down lists of third countries, territories or parts thereof authorised for the introduction into the European Union of certain animals and fresh meat and the veterinary certification requirements [5] lays down the veterinary certification requirements for the introduction into the Union of certain consignments of live animals or fresh meat.
Uredba Komisije (EU) št. 206/2010 z dne 12. marca 2010 o seznamih tretjih držav, njihovih ozemelj ali delov, iz katerih se odobri vnos nekaterih živali in svežega mesa v Evropsko unijo, ter o zahtevah za izdajo veterinarskih spričeval [5] določa zahteve za izdajo veterinarskih spričeval za vnos nekaterih pošiljk živih živali ali svežega mesa v Unijo.
Annexes I and II thereto lay down lists of third countries, territories or parts thereof from which consignments of those animals and meat may be introduced into the Union.
Prilogi I in II k Uredbi določata tudi sezname tretjih držav, njihovih ozemelj ali delov, iz katerih je dovoljen vnos pošiljk navedenih živali in mesa v Unijo.
In addition, Annex I to Regulation (EU) No 206/2010 sets out specific conditions for the introduction into the Union of domestic bovine animals intended for breeding and production, together with a model veterinary certificate for those animals, including Bubalus and Bison species, and their cross-breeds (BOV-X).
Poleg tega so v Prilogi I k Uredbi (EU) št. 206/2010 navedeni specifični pogoji za vnos domačega goveda za vzrejo in proizvodnjo v Unijo, skupaj z vzorcem veterinarskega spričevala za navedene živali, vključno z vrstami bivolov (Bubalus) in bizonov (Bison) ter njunimi križanci (BOV-X).
Special condition ‘IVb’ of Annex I to Regulation (EU) No 206/2010 refers to ‘territory with approved holdings recognised as having an official enzootic-bovine-leukosis (EBL) free status for the purposes of exports to the Union of live animals certified according to the model of certificate (BOV–X)’.
Posebni pogoj „IVb“ Priloge I k Uredbi (EU) št. 206/2010 se nanaša na „ozemlje z odobrenimi kmetijskimi gospodarstvi, priznanimi kot uradno prostimi enzootske goveje levkoze (EGL), za izvoz živih živali v Unijo, ki jih spremlja veterinarsko spričevalo v skladu z vzorcem (BOV-X)“.
That special condition should be amended to take account of the provisions concerning officially enzootic-bovine-leukosis-free herds laid down in Directive 64/432/EEC.
Ta posebni pogoj je treba spremeniti tako, da bo upošteval določbe glede čred, uradno prostih enzootske goveje levkoze iz Direktive 64/432/EGS.
Accordingly, specific condition IVb set out in Part 1 of Annex I to Regulation (EU) No 206/2010 and model of veterinary certificate (BOV-X) set out in Part 2 of that Annex should therefore be amended accordingly.
Zato je posebni pogoj IVb iz dela 1 Priloge I k Uredbi (EU) št. 206/2010 in vzorec veterinarskega spričevala (BOV-X) iz dela 2 navedene priloge treba ustrezno spremeniti.
In addition, Part 6 of Annex I to Regulation (EU) No 206/2010 should be amended to take account of the flurorescence polarization essay diagnostic test set out in Directive 64/432/EEC.
Poleg tega je del 6 Priloge I k Uredbi (EU) št. 206/2010 treba spremeniti tako, da bo upošteval diagnostični test s fluorescentnimi označevalci iz Direktive 64/432/EGS.